Skip to content

The effect of glutamine and creatine co-supplementation in hemodialysis patients

The effect of glutamine and creatine co-supplementation on malnutrition, quality of life, and functional indicators in hemodialysis patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130903014551N14
Enrollment
70
Registered
2025-05-14
Start date
2025-05-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease (CKD) Requiring Hemodialysis. Dependence on renal dialysis

Interventions

Intervention 1: Intervention group: For 12 weeks, participants will receive one packet of supplements daily containing 3 grams of glutamine, 2 grams of creatine, and 1 gram of dextrose (for flavor imp

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: They must have been under hemodialysis treatment for at least 3 months. They must undergo dialysis at least 3 times a week. They should not be under the supervision of another study. They should not be pregnant or breastfeeding. They should not have other diseases such as cancer, advanced liver disease, bipolar disorder, or heart failure. They should not have taken medications or supplements that affect the dependent variables, such as L-carnitine, protein supplements, albumin vials, or any nutritional supplements that they have started or changed the dosage of in the past month. They should not have enteral or parenteral nutrition. The patients should be 18 years or older. They should not be candidates for kidney transplant surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Serum albumin. Timepoint: Measurement of serum albumin before the intervention begins and at the end of the twelfth week. Method of measurement: Blood sample and using the Bromocresol Green method.;Fatigue levels. Timepoint: Measurement of fatigue levels before the intervention begins and at the end of the twelfth week. Method of measurement: MFI-20 questionnaire.;Handgrip strength. Timepoint: Measurement of handgrip strength before the intervention begins and at the end of the twelfth week. Method of measurement: Based on the Southampton method using the handgrip device (SH5002 SAEHAN Spring).;Quality of life levels. Timepoint: Measurement of quality of life levels before the intervention begins and at the end of the twelfth week. Method of measurement: Kidney Disease Quality of Life Questionnaire (KDQOL).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Rouhani

Esfahan University of Medical Sciences

s_m_rouhani2003@yahoo.com+98 31 3792 3183

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026